Neurontin Judge Won't Certify 3rd-Party Bipolar Class

Law360, New York (May 18, 2011, 2:16 PM EDT) -- A Massachusetts judge in charge of the multidistrict litigation over Pfizer Inc.'s Neurontin refused again Tuesday to certify a subclass of third-party payors accusing the drug giant of fraudulently promoting the epilepsy drug to treat bipolar disorder.

The multidistrict litigation against Pfizer consolidated cases filed by consumers and health insurance companies around the country accusing the drug company of pushing off-label uses of Neurontin that studies showed were not effective.

The third-party payors in the subclass, which include health plans and others that paid for Neurontin...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.